Impact of Ravulizumab on Patient Outcomes and Quality of Life in Generalized Myasthenia Gravis

Myasthenia gravis (MG) is an autoimmune ion channel disorder in which antibodies to different end-plate antigens impair neuromuscular transmission, ultimately leading to muscle weakness and fatigability. In about 85% of patients with MG, autoantibodies against the acetylcholine receptor (AChR) activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Antozzi, Carlo, Mantegazza, Renato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590807/
https://www.ncbi.nlm.nih.gov/pubmed/37876920
http://dx.doi.org/10.2147/PROM.S408175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590807/
https://www.ncbi.nlm.nih.gov/pubmed/37876920
http://dx.doi.org/10.2147/PROM.S408175

Ejemplares similares